PharmaPROP.BXL SRL
PharmaPROP.BXL reported total assets of 883,204 € at the end of the 2024 financial year (annual accounts filed with the NBB on 13 Feb 2026).
The score of PharmaPROP.BXL shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PharmaPROP.BXL's annual accounts
| 2024 | |
|---|---|
| Net result | −2,163 € |
| Equity | −1,163 € |
| Cash | 7,579 € |
| EBITDA | 46,079 € |
| Total assets | 883,204 € |
Filed annual accounts
- Year ended 30 Jun 2024filed on 13 Feb 2026
PharmaPROP.BXL's financial analysis
- Solvency-0.1%sector median: 60.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PharmaPROP.BXL
PharmaPROP.BXL's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0804.643.803
- VAT number
- BE0804643803
- Peppol
- Registered · 0208:0804643803 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Aug 2023
- Registered office
- 1000 Brussels
- Latest accounts
- 2024 · filed on 13 Feb 2026
- Activity
- Activities of holding companies (NACE 64210)
PharmaPROP.BXL (SRL) has been based in Brussels since 2023, active in: activities of holding companies. For 2024, it reports a net loss of 2,163 € and equity of −1,163 €; its revenue is not published. Its solvency stands at -0.1%, below the median of its sector (60.1%).
Companies similar to PharmaPROP.BXL
Companies in the same business, of comparable size and area, outside its group.
- P & A Beheer Rental and operating of own or leased real estate Nazareth-De Pinte · balance sheet 883,146 €
- Zakenkantoor Stubbe Fund management activities Sint-Gillis-Waas · balance sheet 883,490 €
- DWS Consultancy Activities of holding companies Bruges · balance sheet 883,819 €
- Patribyt Kortrijk · balance sheet 884,035 €
- Sluishoeve Buying and selling of own real estate Brussels · balance sheet 884,043 €
- E-GO Holding Activities of holding companies Alken · balance sheet 882,358 €
- Invest Wavre Rental and operating of own or leased real estate Schaerbeek · balance sheet 884,721 €
- Ousia Activities of holding companies Chaudfontaine · balance sheet 884,760 €
Frequently asked questions about PharmaPROP.BXL
What is the revenue of PharmaPROP.BXL?
PharmaPROP.BXL files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of PharmaPROP.BXL?
In Belgium, the VAT number is the company number prefixed with BE: BE0804643803 for PharmaPROP.BXL, if the company is VAT-registered. Its company number (CBE) is 0804.643.803.
Where is the registered office of PharmaPROP.BXL?
According to the CBE register, the registered office of PharmaPROP.BXL is in 1000 Brussels.
What is the equity of PharmaPROP.BXL?
At the close of the 2024 financial year, the equity of PharmaPROP.BXL amounts to -1,163 €, a solvency of -0.1% of total assets.
Who manages PharmaPROP.BXL?
The register lists 3 active mandates at PharmaPROP.BXL. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PharmaPROP.BXL
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →